Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
decitabine dna (cytosine-5)-methyltransferase 1 small molecule NA drugbank , DGIDB Refractory anemias[MeSHID:D000753]
Refractory anaemia with excess blasts[MeSHID:D000754]
MYELODYSPLASTIC SYNDROME[MeSHID:D009190]
Leukemia
Myelomonocytic
Chronic[MeSHID:D015477]
Sideroblastic anemia[MeSHID:D000756]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 3.43 approved,investigational inhibitor
decitabine dna (cytosine-5)-methyltransferase 3a small molecule NA drugbank , DGIDB Refractory anemias[MeSHID:D000753]
Refractory anaemia with excess blasts[MeSHID:D000754]
MYELODYSPLASTIC SYNDROME[MeSHID:D009190]
Leukemia
Myelomonocytic
Chronic[MeSHID:D015477]
Sideroblastic anemia[MeSHID:D000756]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 7.23 approved,investigational inhibitor
decitabine dna (cytosine-5)-methyltransferase 3b small molecule NA drugbank Refractory anemias[MeSHID:D000753]
Refractory anaemia with excess blasts[MeSHID:D000754]
MYELODYSPLASTIC SYNDROME[MeSHID:D009190]
Leukemia
Myelomonocytic
Chronic[MeSHID:D015477]
Sideroblastic anemia[MeSHID:D000756]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
decitabine dna small molecule NA drugbank Refractory anemias[MeSHID:D000753]
Refractory anaemia with excess blasts[MeSHID:D000754]
MYELODYSPLASTIC SYNDROME[MeSHID:D009190]
Leukemia
Myelomonocytic
Chronic[MeSHID:D015477]
Sideroblastic anemia[MeSHID:D000756]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational unknown
click here to return to the previous page